1. Alberts DS, Salmon SE, Chen HSG, Moon TE, Young L, Surwit EA (1981) Pharmacologic studies of anticancer drugs with the human tumor stem cell assay. Cancer Chemother Pharmacol 6:253
2. Clinical brochure (July 1979) Aclacinomycin A (NSC-208734). Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment, National Cancer Institute, Bethesda, Maryland
3. Danchev D, Slioussartchouk V, Paintrand M, Hayat M, Bourut C, Mathe G (1979) Electron microscopic studies of the heart and light microscopic studies of the skin after treatment of golden hamsters with Adriamycin, detouribicin, AD 32, and aclacinomycin. Cancer Treat Rep 63:931
4. Dorr RT, Bozak KA, Shipp NG, Hendrix M, Alberts DS, Ahman F (1988) In vitro rat myocyte cardiotoxicity model for antitumor antibiotics using adenosine triphosphate/protein ratios. Cancer Res 48:5222
5. Forastiere AA, Budman DR, Richards F, Aisner J, Weinberg V, Wood WC (1985) Phase II trial of aclacinomycin in advanced breast cancer: a Cancer and Leukemia Group B study. Cancer Treat Rep 67:1137